During the past decade, Adams Cancer Center conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 58 clinical trials were completed, i.e. on average, 75.3% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 36 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adams Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 47 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "Radiation Therapy Oncology Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adams Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Adams Cancer Center" are "Stage IV Lung Cancer AJCC v8" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Prostate Cancer" (7 trials) and "Stage IVA Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Adams Cancer Center" in a lesser frequency.

Most popular intervention types in "Adams Cancer Center" are "Drug" (101 trials), "Other" (82 trials), "Biological" (45 trials), "Radiation" (37 trials) and "Procedure" (31 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (35 trials), "Questionnaire Administration" (20 trials), "Biospecimen Collection" (16 trials) and "Computed Tomography" (16 trials). Other intervention names were less common.

The vast majority of trials in "Adams Cancer Center" are 94 trials for "All" genders, 22 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Adams Cancer Center". undefined are not yet recruiting, 25 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Adams Cancer Center, 3 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Adams Cancer Center, 2 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".